Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid β-peptide

Amyloid

Volumn 4, Issue 4, 1997, Pages 240-252

  Jao, Shu Chuan ^a   Ma, Kan ^a   Talafous, Joseph ^a   Orlando, Ron ^b   Zagorski, Michael G ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Amyloidosis; Nuclear magnetic resonance; Trifluoroacetic acid; peptide

Indexed keywords

EID: 0001146033     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129709003835     Document Type: Article

References (64)

1. Selkoe DJ (1994). Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17, 489-517
2. Iversen LL, Mortishire-Smith RJ, Pollack SJ and Shearman MS (1995). The toxicity in vitro of β-amyloid protein. Biochem. J. 311, 1-16
3. Gravina SA, Ho L, Eckman CB, Long KE, Otvos Jr. L, Younkin LH, Suzuki N and Younkin SG (1995). Amyloid β protein (Aβ) in Alzheimer's Disease brain. J. Biol. Chem. 270, 7013-7016
4. Hendriks L and Van Broeckhoven C (1996). The βA4 amyloid precursor protein gene and Alzheimer's Disease. Eur. J. Biochem. 237, 6-15
5. Tischer E and Cordell B (1996). β-amyloid precursor protein. J. Biol. Chem. 271, 21914-21919
6. Choo L-Pi, Wetzel DL, Halliday WC, Jackson M, LeVine SM and Mantsch HH (1996). In situ characterization of β-amyloid in Alzheimer's diseased tissue by synchroton fourier transform infrared microspectroscopy. Biophys. J. 71, 1672-1679
7. Halverson K, Fraser PE, Kirschner DA and Lansbury PT (1990). Molecular determinants of amyloid deposition in Alzheimer's Disease. Biochemistry 29, 2639-2644
8. Barrow CJ and Zagorski MG (1991). Solution structures of β peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179-182
9. Hilbich C, Kisters-Woide B, Reed J, Masters CL and Beyreuther K (1991). Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's Disease. J. Mol. Biol. 218, 149-163
10. Shen C-L, Fitzgerald MC and Murphy RM (1994). Effect of acid predissolution on fibril size and fibril flexibility of synthetic β-amyloid peptide. Biophys. J. 67, 1238-1246
11. Snyder SW, Ladror US, Wade WS, Wang GT, Barrett LW, Matayoshi ED, Huffaker HJ, Krafft GA and Holzman TF (1994). Amyloid-β aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67, 1216-1228
12. Lee JP, Stimson ER, Ghilardi JR, Mantyh PW, Lu Y-A, Felix AM, Llanos W, Behbin A, Cummings M, van Criekinge M, Timms W and Maggio JE (1995). 1H NMR of Aβ amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence. Biochemistry 34, 5191-5200
13. Soto C, Castano EM, Frangione B and Inestrosa NC (1995). The α-helical to β-strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation. J. Biol. Chem. 270, 3063-3067
14. Terzi E, Hölzemann G and Seelig J (1995). Self-association of β-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252, 633-642
15. Lomakin A, Chung DS, Benedek GB, Kirschner DA and Teplow DB (1996). On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. 93, 1125-1129
16. Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN and Li W (1994). Secondary structure of β-amyloid peptide correlates with toxicity In Vitro. Mol. Pharmacol. 45, 373-379
17. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG and Cotman CW (1995). Structure-activity analysis of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265
18. Gorévic PD, Castano EM, Sarma R and Frangione B (1987). Ten to fourteen residue peptides of Alzheimer's Disease protein are suffcient for amyloid fibril formation and its characteristic diffraction pattern. Biochem. Biophys. Res. Commun. 147, 854-862
19. Kirschner DA, Inouye H, Duffy LK, Sinclair A, Lind M and Selkoe DJ (1987). Synthetic peptide homologous to β-protein from Alzheimer Disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. U.S.A. 84, 6953-6957
20. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Menschen A, Yates J, Cotman C and Glabe C (1992). Assembly and aggregational properties of synthetic Alzheimer's A4/ β amyloid peptide analogs. J. Biol. Chem. 267, 546-554
21. Terzi E, Hölzemann G and Seelig J (1994). Reversible random coil-β-sheet transition of the Alzheimer β-amyloid fragment (25-35). Biochemistry 33, 1345-1350
22. Jarrett JT and Lansbury PT (1993). Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's Disease and scrapie? Cell 73, 1055-1058
23. Tamaoka A, Kondo T, Odaka A, Sahara N, Sawamura N, Ozawa K, Suzuki N, Shoji S and Mori H (1994). Biochemical evidence for the long-tail form (Aβ1-43/43) of amyloid β protein as a seed molecule in cerebral deposits of Alzheimer's Disease. Biochem. Biophys. Res. Commun. 205, 834-842
24. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E and Ball MJ (1993). β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's Disease. Proc. Natl. Acad. Sci. USA 90, 10836-10840
25. Suzuki N, Cheung TT, Cai X-D, Odaka A, Otvos L, Eckman C, Golde TE and Younkin SG (1994). An increased percentage of long amyloid β protein secreted by familial β protein precursor (βAPP717) mutants. Science 264, 1336-1340
26. Citron M, Diehl TS, Gordon G, Biere AL, Seubert P and Selkoe DJ (1996). Evidence that the 42-and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. 93, 13170-13175
27. Harrigan MR, Kunkel DD, Nguyen LB and Malouf AT (1995). Beta amyloid is neurotoxic in hippocampal slice cultures. Neurobiol. Aging 16, 779-789
28. Soto C, Castaño EM, Kumar RA, Beavis RC and Frangione B (1995). Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure. Neurosci. Lett. 200, 105-108
29. Bush AI, Pettingell WH, Multhaup G, Paradis M, Vonsattel J-P, Gusella JF, Beyreuther K, Masters CL and Tanzi RE (1994). Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265, 1464-1467
30. Esler WP, Stimson ER, Jennings JM, Ghilardi JR, Mantyh PW and Maggio JE (1996). Zinc-induced aggregation of human and rat β-amyloid peptides In Vitro. J. Neurochem. 66, 723-732
31. Barrow CJ, Yasuda A, Kenny PTM and Zagorski MG (1992). Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's Disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225, 1075-1093
32. Shen C-L and Murphy RM (1995). Solvent effects on self-assembly of β-amyloid peptide. Biophys. J. 69, 640-651
33. Salomon AR, Marcinowski KJ, Friedland RP and Zagorski MG (1996). Nicotine inhibits amyloid formation by the β-peptide. Biochemistry 35, 13568-13578
34. Sayre LM, Zagorski MG, Surewicz WK, Krafft GA and Perry G (1997). Mechanisms of neurotoxicity with amyloid β deposition and the role of free radicals in the pathogenesis of Alzheimer's Disease. A critical appraisal. Chem. Res. Toxicol. 10, 518-526
35. Zagorski MG and Barrow CJ (1992). NMR Studies of Amyloid β-Peptides: Proton assignments, secondary structure, and mechanism of an α-helix⇒β-sheet conversion for a homologus, 28-residue, N-terminal fragment. Biochemistry 31, 5621-5631
36. Talafous J, Marcinowski KJ, Klopman G and Zagorski MG (1994). Solution structure of residues 1-28 of the amyloid β-peptide. Biochemistry 33, 7788-7796
37. Kohno T, Kobayashi K, Maeda T, Saot K and Takashima A (1996). Three-dimensional structures of the amyloid β peptide (25-35) in membrane-mimicking environment. Biochemistry 35, 16094-16104
38. Fletcher TG and Keire DA (1997). The interaction of β-amyloid protein fragment (12-28) with lipid environments. Protein Science 6, 666-675
39. Boyes BE, Efficient high yield reversed-phase HPLC separations of amyloid precursor polypeptide C-terminal fragments, 14th American Peptide Symposium, Columbus, OH, 1995.
40. Gordon AJ and Ford RA (1972). The Chemist's Companion, (New York: Wiley & Sons)
41. Sticht H, Bayer P, Willbold D, Dames S, Hilbich C, Beyreuther K, Frank RW and Rösch P (1995). Structure of amyloid A4-(1-40)-peptide of Alzheimer's Disease. Eur. J. Biochem. 233, 293-298
42. Bodanszky M and Bodanszky A (1994). The Practice of Peptide Synthesis,. (Berlin: Springer-Verlag)
43. Koksch B, Sewald N, Jakubke H-D and Burger K (1996). Synthesis and Incorporation of a-Trifluoromethyl-Substituted Amino Acids into Peptides, pp. 42-58 (Washington, DC: American Chemical Society)
44. Biemann K (1992). Mass spectrometry of peptides and proteins. Annu. Rev. Biochem. 61, 977-1010
45. Conley RT (1972). Infrared Spectroscopy,. (Boston: Allyn& Bacon, Inc.)
46. Cantor CR and Schimmel PR (1980). Biophysical chemistry: Part II, Techniques for study of biological structure and function. 468-472
47. Halverson KJ, Sucholeiki I, Ashburn TT and Lansbury PT (1991). Location of β-sheet-forming sequences in amyloid proteins by FTIR. J. Am. Chem. Soc. 113, 6701-6703
48. Surewicz WK, Mantsch HH and Chapman D (1993). Determination of protein secondary structure by fourier transform infrared spectroscopy: a critical assessment. Biochemistry 32, 389-394
49. Southwick PC, Yamagata SK, Echols CL, Higson GJ, Neynaber SA, Parson Re and Munroe WA (1996). Assessment of amyloid β protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's Disease. J. Neurochem. 66, 259-265
50. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL and Beyreuther K (1985). Amyloid plaque core protein in Alzheimer Disease and Down Syndrome. Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249
51. Wood SJ, MacKenzie L, Maleef B, Hurle MR and Wetzel R (1996). Selective inhibition of Aβ fibril formation. J. Biol. Chem. 271, 4086-4092
52. Yankner B, Duffy L and Kirschner D (1990). Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279-282
53. Mattson MP, Tomaselli KJ and Rydel RE (1993). Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49
54. Whitson JS, Mims MP, Strittmatter WJ, Yamaki T, Morrisett JD and Appel SH (1994). Attenuation of the neurotoxic effect of Aβ amyloid peptide by apolipoprotein E. Biochem. Biophys. Res. Comm. 199, 163-170
55. Roher AE, Chaney MO, Kuo Y-M, Webster SD, Stine WB, Haverkamp LJ, Woods AS, Cotter RJ, Tuohy JM, Krafft GA, Bonnell BS and Emmerling MR (1996). Morphology and toxicity of Aβ(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's Disease. J. Biol. Chem. 271, 20631-20635
56. Klunk WE and Pettegrew JW (1990). Alzheimer's β-amyloid protein is covalently modified when dissolved in formic acid. Journal of Neurochemistry 54, 2050-2056
57. Wisniewski T, Lalowski M, Bobik M, Russell M, Strosznajder J and Frangione B (1996). Amyloid β 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs. Biochem. J. 313, 575-580
58. Orlando R, Kenny PTM and Zagorski MG (1992). Covalent modification of Alzheimer's amyloid β-peptide in formic acid solutions. Biochem. Biophys. Res. Commun. 184, 686-691
59. Busciglio J, Lorenzo A and Yanker BA (1992). Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging 13, 609-612
60. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I and Rydel RE (1992). β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. Res. 12, 376-389
61. Urban J, Vaisar T, Shen R and Lee MS (1996). Lability of N-alkylated peptides towards TFA cleavage. Int. J. Peptide Protein Res. 47, 182-189
62. Kaneko I and Tutumi S (1997). Conformations of β-amyloid in solution. J. Neurochem. 68, 438-439
63. Butterfield DA, Hensley K, Harris M, Mattson M and Carney J (1994). β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's Disease. Biochem. Biophys. Res. Commun. 200, 710-715
64. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA and Butterfield DA (1994). A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer Disease. Proc. Natl. Acad. Sci., USA 91, 3270-3274